My research is focused on the mathematical modelling of infectious diseases like tuberculosis, COVID-19 and RSV, among others, from different perspectives. We use computational models to better understand the natural history of tuberculosis inside the lungs, using a virtual bronchial tree where we implement an agent-based model that describes the dynamics of granulomas. We also adrress the epidemiological dynamics of different respiratory viral and bacterial infections, identifying the main drivers and exploring the predictive capacity of models.
1-
Early experience on universal prophylaxis in infants against respiratory syncytial virus: facts and expectationsSoriano Arandes, Antoni; Creus, A.; Perramon, A.; Andrés, C.; Vila, J.; Gatell, A.; Piñana, M.; Serrano, P.; González, A.; Capdevila, R.; Prats, C.; Soler-Palacín, P.; Antón, A.Seminars in respiratory and critical care medicine
46, 31-40 (2025)
2-
Implementing symptom-based predictive models for early diagnosis of pediatric respiratory viral infectionsSoriano Arandes, Antoni; Andrés, C.; Perramon, A.; Creus, A.; Gatell, A.; Martín, R.; Solà-Segura, E.; Riera, M.; Fernández, E.; Biosca, M.; Capdevila, R.; Sánchez, A.; Soler, I.; Chiné, M.; Sanz, L.; Quezada, G.; Pérez, S.; Canadell, D.; Salvadó, O.; Ridao, M.; Sau, I.; Rifà, M.; Macià, E.; Burgaya, S.; Vilà, M.; Vila, J.; Mejías, A.; Antón, A.; Soler-Palacín, P.; Prats, C.Viruses
17, 4, article 546 (2025)
3-
Real-world impact of nirsevimab immunisation against respiratory disease on emergency department attendances and admissions among infants: a multinational retrospective analysisPerramon, A.; Buonsenso, D.; Morello, R.; Coma, E.; Foster, S.; Leonard, P.; Marlow, R.; Martinez, M.; Mendioroz, J.; Vila, J.; Creus-Costa, A.; Prats, C.; Roland, D.; Williams, T.; Soriano-Arandes, A.The Lancet regional health. Europe
, article 101334 (2025)
4-
Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital care settings: a seasonal cohort study of infants in Catalonia (Spain)Perramon, A.; Hermosilla, E.; Coma, E.; Fina, F.; Reñé, A.; Martinez, M.; Mendioroz, J.; Prats, C.; Soriano Arandes, Antoni; Cabezas, C.Pediatric infectious disease journal
44, 394-398 (2025)
6-
Country-report pattern corrections of new cases allow accurate 2-week predictions of COVID-19 evolution with the Gompertz modelVillanueva, M.; Conesa, D.; Català, M.; Perramon, A.; Lopez de Rioja, V.; Lopez, D.; Alonso, S.; Cardona, P.J.; Prats, C.; Alvarez-Lacalle, E.; López, M.; Molinuevo, D.; Montañola, C.Scientific reports
14, 10775 (2024)
7-
Mathematical modeling of SARS-CoV-2 variant substitutions in European countries: transmission dynamics and epidemiological insightsLopez de Rioja, V.; Perramon, A.; Alonso, S.; Andrés, C.; Antón, A.; Bordoy, A.; Càmara, J.; Cardona, P.J.; Català, M.; Lopez, D.; Martí, S.; Martró, E.; Saludes, V.; Prats, C.; Alvarez-Lacalle, E.Frontiers in public health
12, (2024)
8-
Severity of Omicron subvariants and vaccine impact in Catalonia, SpainLopez de Rioja, V.; Basile, L.; Perramon, A.; Martinez-Solanas, È.; Lopez, D.; Medina-Maestro, S.; Coma, E.; Fina, F.; Prats, C.; Mendioroz, J.; Alvarez-Lacalle, E.Vaccines
12, 466 (2024)
9-
The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complicationsMercadé, N.; Li, X.; Kolde, R.; Trinh, N.; Sanchez, M.; Man, W.; Roel, E.; Reyes, C.; Delmestri, A.; Nordeng, H.; Uusküla, A.; Duarte-Salles, T.; Prats, C.; Prieto-Alhambra, D.; Català, M.Heart (London. 1996)
110, 635-643 (2024)
12-
Effect of genetically predicted sclerostin on cardiovascular biomarkers, risk factors, and disease outcomesAlcalde-Herraiz, M.; Xie, J.; Newby, D.; Prats, C.; Gill, D.; Gordillo-Marañón, M.; Prieto-Alhambra, D.; Català, M.; Prats-Uribe, A.Nature communications
15, article 9832 (2024)
13-
Introduction of nirsevimab in Catalonia, Spain: description of the incidence of bronchiolitis and respiratory syncytial virus in the 2023/2024 seasonPerramon, A.; Lopez de Rioja, V.; Coma, E.; Hermosilla, E.; Fina, F.; Martínez-Marcos, M.; Mendioroz, J.; Cabezas, C.; Montañola-Sales, C.; Prats, C.; Soriano-Arandes, A.European journal of pediatrics
183, 5181-5189 (2024)
14-
Development of a low-cost robotized 3D-prototype for automated optical microscopy diagnosis: an open-source systemOliveira AD; Rubio, C.; Zarzuela , F.; Carvalho, B.; Sulleiro, E.; Prats, C.; Veiga , A.; Bosch, M.; Zulueta, J.; Abello, A.; Sayrol, E.; Joseph, J.; Lopez, D.PloS one
19, 6, article e0304085 (2024)
15-
A semi-empirical risk panel to monitor epidemics: multi-faceted tool to assist healthcare and public health professionalsPerramon, A.; Bravo, M.; Lopez de Rioja, V.; Català, M.; Alonso, S.; Alvarez-Lacalle, E.; Lopez, D.; Soriano-Arandes, A.; Prats, C.Frontiers in public health
11, 1307425 (2024)
16-
Respiratory viral coinfections in pediatric patients in the primary care setting: a multicenter prospective study within the COPEDICAT networkAndrés, C.; Perramon, A.; Creus-Costa, A.; Gatell, A.; Martín-Martín, R.; Solà-Segura, E.; Ribera-Bosch, M.; Biosca, M.; Soler, I.; Chiné, M.; Sanz, L.; Quezada, G.; Pérez, S.; Salvadó, O.; Sau, I.; Prats, C.; Antón, A.; Soriano-Arandes, A.Journal of infectious diseases
230, 1337-1341 (2024)
17-
Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain)Coma, E.; Martinez, M.; Hermosilla, E.; Mendioroz, J.; Reñé, A.; Fina, F.; Perramon, A.; Prats, C.; Cereza, M.; Ciruela, P.; Pineda, V.; Antón, A.; Ricós Furió, G.; Soriano Arandes, Antoni; Cabezas, C.Archives of disease in childhood
, 736-741 (2024)
20-
Unraveling the effects of the COVID-19 pandemic on the hospital burden of respiratory syncytial virusPerramon, A.; Lopez de Rioja, V.; Montañola-Sales, C.; Vila, J.; Antón, A.; Piñana, M.; Soler-Palacín, P.; Prats, C.; Soriano-Arandes, A.; Creus, A.; Andrés, C.; Lera, E.; Wörner, N.; Balcells, J.Pediatric pulmonology
58, 2979-2982 (2023)
21-
Mortality in Catalonia during the summer of 2022 and its relation with high temperatures and COVID-19 casesComa, E.; Pino, D.; Mora, N.; Moras, N.; Fina, F.; Perramon, A.; Prats, C.; Medina, M.; Planella, A.; Mompart, A.; Mendioroz, J.; Cabezas, C.Frontiers in public health
11, (2023)
23-
Predictive performance of multi-model ensemble forecasts of COVID-19 across European nationsSherratt, K.; Gruson, H.; Johnson, H.; Grah, R.; Niehus, R.; Villanueva, I.; Alonso, S.; Alvarez-Lacalle, E.; Lopez, D.; Prats, C.; Català, M.; Funk, S.eLife
12, Article e81916 (2023)
24-
SARS-CoV-2 transmission in teenagers and young adults in Fútbol Club Barcelona’s Multidisciplinary Sports Training AcademyHernández, M.; Bassat, Q.; Fumadó, V.; Rodas, G.; Pi, R.; Miranda, M.; Girona, M.; Català, M.; Alonso, S.; Alvarez-Lacalle, E.; Lopez, D.; Mele-Casas, M.; Pons, G.; Fernández de Sevilla, M.; Bonet-Carne, E.; Prats, C.European journal of pediatrics
182, 2421-2432 (2023)
26-
Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, SpainPino, R.; Antoñanzas, J.; Paredes-Carmona, F.; Perramon, A.; Rivière, J.; Martínez, A.; Gatell, A.; Soler-Palacín, P.; Fina, F.; Prats, C.; Soriano-Arandes, A.European journal of pediatrics
182, 1897-1909 (2023)
27-
Low transmission of SARS-CoV-2 derived from children in family clusters: An observational study of family households in the Barcelona Metropolitan Area, SpainMele-Casas, M.; Launes, C.; Fernández de Sevilla, M.; Bassat, Q.; Fumadó, V.; Garcia-Miquel, A.; Bonet-Carné, E.; Prats, C.; Ajanovic, S.; Jou, C.; Balanza, N.; Baro, B.; Millat-Martínez, P.; Alonso, S.; Alvarez-Lacalle, E.; Català, M.; Cuadras, D.; Muñoz-Almagro, C.; Gratacós, E.; Jordan, I.PloS one
17, 11 (2022)
30-
Assessing wastewater-based epidemiology for the prediction of SARS-CoV-2 incidence in CataloniaJoseph-Duran, B.; Serra-Compte, A.; Sàrrias, M.; Gonzalez, S.; Lopez, D.; Prats, C.; Català, M.; Alvarez-Lacalle, E.; Alonso, S.; Arnaldos, M.Scientific reports
12, 1 (2022)
32-
Unravelling the role of the mandatory use of face covering masks for the control of SARS-CoV-2 in schools: a quasi-experimental study nested in a population-based cohort in Catalonia (Spain)Coma, E.; Català, M.; Méndez-Boo, L.; Alonso, S.; Hermosilla, E.; Alvarez-Lacalle, E.; Pino, D.; Medina, M.; Asso, L.; Gatell, A.; Bassat, Q.; Mas, A.; Soriano-Arandes, A.; Fina, F.; Prats, C.Archives of disease in childhood
105, 1-13 (2022)
33-
Multisystem inflammatory syndrome in children in western countries: decreasing incidence as the pandemic progresses? An observational multicenter international cross-sectional studyBuonsenso, D.; Perramon, A.; Català, M.; Torres, J.; Camacho, G.; Rojas, M.; Ulloa, R.; amacho, K.; Pérez, C.; Cotugno, N.; Yamazaki, M.; Estripeaut, D.; Buddingh, E.; von Asmuth, E.; van Rossum, A.; Rivière, J.; Pino, R.; Prats, C.Pediatric infectious disease journal
41, 12 (2022)
34-
Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysisCatalà, M.; Coma, E.; Alonso, S.; Andres, C.; Blanco, I.; Antón, A.; Escales, A.; Cardona, P.J.; Fina, F.; Martró, E.; Medina, M.; Moras, N.; Saludes Montoro, V.; Prats, C.; Prieto-Alhambra, D.; Alvarez-Lacalle, E.Frontiers in public health
10, 1-13 (2022)
38-
Individual prevention and containment measures in schools in Catalonia, Spain, and community transmission of SARS-CoV-2 after school re-openingAlonso, S.; Català, M.; Lopez, D.; Alvarez-Lacalle, E.; Jordan, I.; Fumadó, V.; Muñoz-Almagro, C.; Gratacós, E.; Balanza, N.; Baro, B.; Ajanovic, S.; Arias, S.; Fernández de Sevilla, M.; Bonet-Carné, E.; Garcia-Miquel, A.; Medina-Peralta, M.; Coma, E.; Fina, F.; Prats, C.; Bassat, Q.PloS one
17, 2 (2022)
39-
Robust estimation of diagnostic rate and real incidence of COVID-19 for European policymakersCatalà, M.; Pino, D.; Marchena, M.; Palacios, P.; Urdiales, T.; Cardona, P.J.; Alonso, S.; Lopez, D.; Prats, C.; Alvarez-Lacalle, E.PloS one
16, e0243701 (2021)
40-
Incidence and impact of COVID-19 in MS. A survey from a Barcelona MS Unit.Sepúlveda, M.; Llufriu, S.; Martínez-Hernández, E.; Català, M.; Artola, M.; Hernando, A.; Montejo, C.; Pulido-Valdeolivas, I.; Martinez-Heras, E.; Guasp, M.; Solana, E.; Llançó, L.; Escudero, D.; Aldea, M.; Prats, C.; Graus, F.; Blanco, Y.; Saiz, A.Neurology-Neuroimmunology & Neuroinflammation
8, e954 (2021)
41-
Transmission of severe acute respiratory syndrome coronavirus 2 infection among children in summer schools applying stringent control measures in Barcelona, SpainJordan, I.; Fernández de Sevilla, M.; Fumadó, V.; Bassat, Q.; Bonet-Carné, E.; Fortuny, C.; Garcia-Miquel, A.; TOMAS, G.; Arias, S.; Alonso, S.; Alvarez-Lacalle, E.; Cuadras, D.; Català, M.; Lopez, D.; Prats, C.; García-García, J.; Gratacós, E.Clinical infectious diseases
74, 66-73 (2021)
42- "Reply to Darcis, et al"
Soriano-Arandes, A.; Perramon, A.; Gatell, A.; Serrano, P.; Prats, C.; Soler, P.
Clinical infectious diseases , ciab572 (2021)
43-
Knowledge and challenges of covid-19 in the paediatric population conocimientos y retos sobre covid-19 y población pediátricaSerrano, P.; Gatell, A.; Valldepérez, C.; Capdevila, R.; Vila, M.; Canadell , .; Ricós, G.; López, N.; Martínez, A.; Soriano Arandes, Antoni; Prats, C.Pediatria de Atencion Primaria
23, 321-326 (2021)
44-
Risk diagrams based on primary care electronic medical records and linked real-time PCR data to monitor local covid-19 outbreaks during the summer 2020: a prospective study including 7,671,862 people in CataloniaCatalà, M.; Coma, E.; Alonso, S.; Alvarez-Lacalle, E.; Cordomí, S.; Lopez, D.; Fina, F.; Medina-Peralta, M.; Prats, C.; Prieto-Alhambra, D.Frontiers in public health
9, 693956-1-8 (2021)
45-
Monitoring and analysis of COVID-19 pandemic: the need for an empirical approachCatalà, M.; Marchena, M.; Conesa, D.; Palacios, P.; Urdiales, T.; Alonso, S.; Alvarez-Lacalle, E.; Lopez, D.; Cardona, P.J.; Prats, C.Frontiers in public health
9, 633123/1--9 (2021)
46-
Age-dependency of the propagation rate of coronavirus disease 2019 inside school bubble groups in Catalonia, SpainAlonso, S.; Alvarez-Lacalle, E.; Català, M.; Lopez, D.; Jordan, I.; García-García, J.; Soriano-Arandes, A.; Lazcano, U.; Sallés, P.; Masats, M.; Urrutia, J.; Gatell, A.; Capdevila, R.; Soler-Palacín, P.; Bassat, Q.; Prats, C.Pediatric infectious disease journal
40, 955-961 (2021)
47-
Schools as a Framework for COVID-19 Epidemiological Surveillance of Children in Catalonia, Spain: A Population-Based StudyPerramon, A.; Soriano-Arandes, A.; Pino, D.; Andres, C.; Català, M.; Gatell, A.; Poblet, M.; Prats, C.Frontiers in Pediatrics
9, 745744 (2021)
49-
Symptom-based predictive model of COVID-19 disease in childrenAntoñanzas, J.; Perramon, A.; López, C.; Boneta, M.; Aguilera, C.; Capdevila, R.; Gatell, A.; Serrano, P.; Poblet, M.; Canadell, D.; Vilà, M.; Catasús, G.; Valldepérez, C.; Català, M.; Soler-Palacín, P.; Prats, C.; Soriano-Arandes, A.Viruses
14, 63 (2021)
50-
A cost–benefit analysis of COVID-19 vaccination in CataloniaLópez, F.; Català, M.; Prats, C.; Estrada, O.; Oliva, I.; Prats, N.; Isnard, M.; Vallès, R.; Vilar, M.; Clotet, B.; Argimon, J.; Aran, A.; Ara, J.Vaccines
10, 10010059:1-10010059:9 (2021)
55-
Modelling the dynamics of tuberculosis lesions in a virtual lung: role of the bronchial tree in endogenous reinfectionCatalà, M.; Bechini, J.; Tenesa, M.; Pérez, R.; Moya, M.; Vilaplana, C.; Valls, J.; Alonso, S.; Lopez, D.; Cardona, P.J.; Prats, C.PLoS computational biology
16, e1007772 (2020)
56-
Cording mycobacterium tuberculosis bacilli have a key role in the progression towards active tuberculosis, which is stopped by previous immune responseArias, L.; Cardona, P.; Català, M.; Prats, C.; Vilaplana, C.; Cardona, P.J.; Julian, E.; Campo, V.Microorganisms
8, 228 (2020)
59-
A microfluidics and agent-based modeling framework for investigating spatial organization in bacterial colonies: the case of Pseudomonas Aeruginosa and H1-Type VI secretion interactionsWilmoth, J.; Doak, P.; Timm, A.; Halsted, M.; Anderson, J.; Ginovart, M.; Prats, C.; Portell, X.; Retterer, S.; Fuentes-Cabrera, M.Frontiers in microbiology
9, 33 (2018)
61-
Can systems immunology lead tuberculosis eradication?Cardona, P.J.; Català, M.; Arch, M.; Arias, L.; Alonso, S.; Cardona, P.; Lopez, D.; Vilaplana, C.; Prats, C.Current Opinion in Systems Biology
12, 53-60 (2018)
65-
The malaria system microApp: A new, mobile device-based tool for malaria diagnosisOliveira, A.; Prats, C.; Espasa, M.; Zarzuela, F.; Montañola-Sales, C.; Silgado, A.; Lopez, D.; Erruda, M.; Gómez, J.; Albuquerque, J.JMIR Research Protocols
6, e70 (2017)
upc.edu